查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1178049

色素沉著過剩障礙治療的全球市場:各治療類型(藥妝品，雷射治療，果酸換膚，微晶換膚術，光線療法，其他)-產業分析，市場規模，佔有率，成長，趨勢，預測(2022年～2031年)

Hyperpigmentation Disorder Treatment Market (Treatment Type: Cosmeceuticals, Laser Therapy, Chemical Peels, Microdermabrasion, Phototherapy, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 113 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球色素沉著過剩障礙治療市場相關調查分析，提供市場概要，市場分析，競爭情形等系統性資訊。

目錄

第1章 序文

第2章 前提與調查手法

第3章 摘要整理:全球色素沉著過剩障礙治療市場

第4章 市場概要

  • 簡介
    • 定義
    • 產業的演進/發展
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球色素沉著過剩障礙治療市場分析與預測(2017年～2031年)

第5章 主要洞察

  • 主要的市場趨勢
  • 合併和收購
  • 在市場活動的主要5企業的策略
  • 整形外科疾病的發生率:各主要國家
  • 法規及償付情勢:各主要國家

第6章 全球色素沉著過剩障礙治療市場分析與預測:各治療類型

  • 簡介和定義
  • 市場金額預測(2017年～2031年):各治療類型
    • 藥妝品
    • 雷射治療
    • 果酸換膚
    • 微晶換膚術
    • 光線療法
    • 其他
  • 市場魅力:各治療類型

第7章 全球色素沉著過剩障礙治療市場分析與預測:各適應症

  • 簡介和定義
  • 市場金額預測(2017年～2031年):各適應症
    • 肝斑
    • 發炎後色素沉著
    • 日光輔佐員
    • 其他
  • 市場魅力分析:各適應症

第8章 全球色素沉著過剩障礙治療市場分析與預測:各終端用戶

  • 簡介和定義
  • 市場金額預測(2017年～2031年):各終端用戶
    • 醫院
    • 美容院·皮膚科
    • 其他
  • 市場魅力分析:各終端用戶

第9章 全球色素沉著過剩障礙治療市場分析與預測:各地區

  • 主要調查結果
  • 市場金額預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力分析:各地區

第10章 北美的色素沉著過剩障礙治療市場分析與預測

第11章 歐洲的色素沉著過剩障礙治療市場分析與預測

第12章 亞太地區的色素沉著過剩障礙治療市場分析與預測

第13章 南美的色素沉著過剩障礙治療市場分析與預測

第14章 中東及非洲的色素沉著過剩障礙治療市場分析與預測

第15章 競爭情形

  • 市場參與企業-競爭矩陣(各等級及各企業規模)
  • 市場佔有率分析(2021年):各企業
  • 企業簡介
    • Aerolase Corporation
    • Candela Corporation
    • Cynosure
    • Galderma SA
    • iSCLINICAL
    • ISDIN
    • L'Oreal(SkinCeuticals, Skinbetterscience &La Roche-Posay)
    • Lumenis Be Ltd.
    • Mesoestetics
    • Obagi Cosmeceuticals LLC
    • PCA Skin
    • Scientis
    • Sente Labs
    • SkinMedica(AbbVie)
    • ZO Skin Health, Inc.
Product Code: TMRGL46644

TMR's report on the global hyperpigmentation disorder treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global hyperpigmentation disorder treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hyperpigmentation disorder treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hyperpigmentation disorder treatment market.

The report delves into the competitive landscape of the global hyperpigmentation disorder treatment market. Key players operating in the global hyperpigmentation disorder treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global hyperpigmentation disorder treatment market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hyperpigmentation Disorder Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Hyperpigmentation Disorder Treatment Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Key Market Trends
  • 5.2. Merger and Acquisition
  • 5.3. Strategies of Top Five Players Operating in the Market
  • 5.4. Incidence of Orthopedic Disorder, by Key Countries
  • 5.5. Regulatory and Reimbursement Scenario, by Key Countries

6. Global Hyperpigmentation Disorder Treatment Market Analysis and Forecast, by Treatment Type

  • 6.1. Introduction & Definition
  • 6.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 6.2.1. Cosmeceuticals
    • 6.2.2. Laser Therapy
    • 6.2.3. Chemical Peels
    • 6.2.4. Microdermabrasion
    • 6.2.5. Phototherapy
    • 6.2.6. Others
  • 6.3. Market Attractiveness, by Treatment Type

7. Global Hyperpigmentation Disorder Treatment Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Market Value Forecast, by Disease Indication, 2017-2031
    • 7.2.1. Melasma
    • 7.2.2. Post-inflammatory Hyperpigmentation
    • 7.2.3. Solar Lentigines
    • 7.2.4. Others
  • 7.3. Market Attractiveness Analysis, by Disease Indication

8. Global Hyperpigmentation Disorder Treatment Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Market Value Forecast, by End-user, 2017-2031
    • 8.2.1. Hospitals
    • 8.2.2. Esthetic Clinics & Dermatology Centers
    • 8.2.3. Others
  • 8.3. Market Attractiveness Analysis, by End-user

9. Global Hyperpigmentation Disorder Treatment Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Hyperpigmentation Disorder Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 10.2.1. Cosmeceuticals
    • 10.2.2. Laser Therapy
    • 10.2.3. Chemical Peels
    • 10.2.4. Microdermabrasion
    • 10.2.5. Phototherapy
    • 10.2.6. Others
  • 10.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 10.3.1. Melasma
    • 10.3.2. Post-inflammatory Hyperpigmentation
    • 10.3.3. Solar Lentigines
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Esthetic Clinics & Dermatology Centers
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Treatment Type
    • 10.6.2. By Disease Indication
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Hyperpigmentation Disorder Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 11.2.1. Cosmeceuticals
    • 11.2.2. Laser Therapy
    • 11.2.3. Chemical Peels
    • 11.2.4. Microdermabrasion
    • 11.2.5. Phototherapy
    • 11.2.6. Others
  • 11.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 11.3.1. Melasma
    • 11.3.2. Post-inflammatory Hyperpigmentation
    • 11.3.3. Solar Lentigines
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Esthetic Clinics & Dermatology Centers
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Treatment Type
    • 11.6.2. By Disease Indication
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Hyperpigmentation Disorder Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 12.2.1. Cosmeceuticals
    • 12.2.2. Laser Therapy
    • 12.2.3. Chemical Peels
    • 12.2.4. Microdermabrasion
    • 12.2.5. Phototherapy
    • 12.2.6. Others
  • 12.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 12.3.1. Melasma
    • 12.3.2. Post-inflammatory Hyperpigmentation
    • 12.3.3. Solar Lentigines
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Esthetic Clinics & Dermatology Centers
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Treatment Type
    • 12.6.2. By Disease Indication
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Hyperpigmentation Disorder Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 13.2.1. Cosmeceuticals
    • 13.2.2. Laser Therapy
    • 13.2.3. Chemical Peels
    • 13.2.4. Microdermabrasion
    • 13.2.5. Phototherapy
    • 13.2.6. Others
  • 13.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 13.3.1. Melasma
    • 13.3.2. Post-inflammatory Hyperpigmentation
    • 13.3.3. Solar Lentigines
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Esthetic Clinics & Dermatology Centers
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Treatment Type
    • 13.6.2. By Disease Indication
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Hyperpigmentation Disorder Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 14.2.1. Cosmeceuticals
    • 14.2.2. Laser Therapy
    • 14.2.3. Chemical Peels
    • 14.2.4. Microdermabrasion
    • 14.2.5. Phototherapy
    • 14.2.6. Others
  • 14.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 14.3.1. Melasma
    • 14.3.2. Post-inflammatory Hyperpigmentation
    • 14.3.3. Solar Lentigines
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Esthetic Clinics & Dermatology Centers
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Treatment Type
    • 14.6.2. By Disease Indication
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company (2021)
  • 15.3. Company Profiles
    • 15.3.1. Aerolase Corporation
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Treatment Type Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Candela Corporation
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Treatment Type Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Cynosure
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Treatment Type Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
    • 15.3.4. Galderma S.A.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Treatment Type Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. iSCLINICAL
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Treatment Type Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. ISDIN
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Treatment Type Portfolio
      • 15.3.6.3. SWOT Analysis
    • 15.3.7. L'Oreal (SkinCeuticals, Skinbetterscience & La Roche-Posay)
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Treatment Type Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Strategic Overview
    • 15.3.8. Lumenis Be Ltd.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Treatment Type Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Strategic Overview
    • 15.3.9. Mesoestetics
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Treatment Type Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Obagi Cosmeceuticals LLC
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Treatment Type Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. PCA Skin
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Treatment Type Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Scientis
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Treatment Type Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview
    • 15.3.13. Sente Labs
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Treatment Type Portfolio
      • 15.3.13.3. SWOT Analysis
      • 15.3.13.4. Financial Overview
      • 15.3.13.5. Strategic Overview
    • 15.3.14. SkinMedica (AbbVie)
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Treatment Type Portfolio
      • 15.3.14.3. SWOT Analysis
      • 15.3.14.4. Financial Overview
      • 15.3.14.5. Strategic Overview
    • 15.3.15. ZO Skin Health, Inc.
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Treatment Type Portfolio
      • 15.3.15.3. SWOT Analysis
      • 15.3.15.4. Financial Overview
      • 15.3.15.5. Strategic Overview

List of Tables

  • Table 01: Global Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 02: Global Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 03: Global Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 07: North America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 08: North America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 11: Europe Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 12: Europe Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 15: Asia Pacific Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 16: Asia Pacific Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 19: Latin America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 20: Latin America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 23: Middle East & Africa Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 24: Middle East & Africa Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Hyperpigmentation Disorder Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2018 and 2031
  • Figure 02: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn), by Treatment Type, 2021
  • Figure 03: Global Hyperpigmentation Disorder Treatment Market Value Share, by Treatment Type, 2021
  • Figure 04: Global Hyperpigmentation Disorder Treatment Market Value Share, by Disease Indication, 2021
  • Figure 05: Global Hyperpigmentation Disorder Treatment Market Value Share, by End-user, 2021
  • Figure 06: Global Hyperpigmentation Disorder Treatment Market Value Share, by Region, 2021
  • Figure 07: Global Hyperpigmentation Disorder Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 08: Global Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
  • Figure 09: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phototherapy, 2017-2031
  • Figure 10: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmeceuticals, 2017-2031
  • Figure 11: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Peels, 2017-2031
  • Figure 12: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microdermabrasion, 2017-2031
  • Figure 13: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laser Therapy, 2017-2031
  • Figure 14: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 15: Global Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 16: Global Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 17: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Melasma, 2017-2031
  • Figure 18: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-inflammatory Hyperpigmentation, 2017-2031
  • Figure 19: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Restorative Surgery, 2017-2031
  • Figure 20: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 21: Global Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 22: Global Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
  • Figure 23: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2031
  • Figure 24: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Esthetic Clinics & Dermatology Centers, 2017-2031
  • Figure 25: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 26: Global Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 27: Global Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Region, 2017 and 2031
  • Figure 28: Global Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 29: North America Hyperpigmentation Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 30: North America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Country, 2017-2031
  • Figure 31: North America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Country, 2017 and 2031
  • Figure 32: North America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
  • Figure 33: North America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 34: North America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
  • Figure 35: North America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 36: North America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 37:North America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 38: Europe Hyperpigmentation Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 39: Europe Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 40: Europe Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 41: Europe Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
  • Figure 42: Europe Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 43: Europe Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
  • Figure 44: Europe Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 45: Europe Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 46: Europe Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 47: Asia Pacific Hyperpigmentation Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 48: Asia Pacific Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 49: Asia Pacific Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 50: Asia Pacific Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
  • Figure 51: Asia Pacific Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 52: Asia Pacific Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
  • Figure 53: Asia Pacific Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 54: Asia Pacific Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 55: Asia Pacific Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 56: Latin America Hyperpigmentation Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 57: Latin America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 58: Latin America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 59: Latin America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
  • Figure 60: Latin America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 61: Latin America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
  • Figure 62: Latin America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 63: Latin America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 64: Latin America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 65: Middle East & Africa Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 66: Middle East & Africa Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 67: Middle East & Africa Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 68: Middle East & Africa Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
  • Figure 69: Middle East & Africa Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
  • Figure 70: Middle East & Africa Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
  • Figure 71: Middle East & Africa Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 72: Middle East & Africa Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 73: Middle East & Africa Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031